Apoptotic Effects of Sanguinarine on the Organ of Corti 1 Cells: Comparison with Cisplatin

被引:3
作者
Cecen, Emre [1 ]
Ercetin, Pinar [2 ]
Kirkim, Gunay [3 ]
Pamukoglu, Ayca [2 ]
Aktas, Safiye [2 ]
Altun, Zekiye [2 ]
Dogan, Ersoy [3 ]
Olgun, Nur [4 ]
机构
[1] Adnan Menderes Univ, Fac Med, Dept Pediat Oncol, Aydin, Turkey
[2] Dokuz Eylul Univ, Inst Oncol, Dept Basic Oncol, Izmir, Turkey
[3] Dokuz Eylul Univ, Fac Med, Dept Otorhinolaryngol, Izmir, Turkey
[4] Dokuz Eylul Univ, Inst Oncol, Dept Pediat Oncol, Izmir, Turkey
关键词
Cisplatin; sanguinarine; ototoxicity; HEI-OC1; cells; BCL-2 FAMILY PROTEINS; CANCER-CELLS; ALKALOID SANGUINARINE; INDUCED OTOTOXICITY; CHELERYTHRINE; DEATH; CYCLE; MODULATION; ACTIVATION; EXPRESSION;
D O I
10.5152/iao.2015.484
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
OBJECTIVE: Sanguinarine is an alkaloid obtained from the root of Sanguinaria canadensis and other plants from the Papaveraceae family and is well known to possess a broad range of biological functions, such as antimicrobial, antifungal, anti-inflammatory, and antineoplastic activities. We aimed to specify the in vitro effect of sanguinarine on the House Ear Institute-Organ of Corti 1 (HEI-OC1) cells and to compare this effect with the ototoxic effect of cisplatin (CDDP). MATERIALS and METHODS: We performed cell proliferation assay for determining the in vitro effect of sanguinarine alone and compared it with the effect of cisplatin. Flow cytometry annexin-V apoptosis detection was performed. RESULTS: We found that sanguinarine and CDDP inhibited the cell growth in a dose-dependant manner in HEI-OC1 cells after 24 h of incubation. In sanguinarine-treated group, apoptosis was 6.6%, necrosis was 26.7%, and the cell viability was 66.7%. Further, in CDDP-treated group, apoptosis was 5.6%, necrosis was 45.4%, and the cell viability was 48.7%. According to the annexin-V apoptosis detection results, we found that sanguinarine caused 3.9% apoptosis and 1.3% necrosis, while CDDP caused 2.9% apoptosis and 20% necrosis on HEI-OC1 cells. CONCLUSION: Our findings suggested that lower doses of sanguinarine are promising antineoplastic agents, which did not indicate any toxic effect on HEI-OC1 cells. Application of these data to clinical practice requires further support by in vivo studies.
引用
收藏
页码:19 / 22
页数:4
相关论文
共 29 条
[1]  
Adhami VM, 2004, MOL CANCER THER, V3, P933
[2]  
Adhami VM, 2003, CLIN CANCER RES, V9, P3176
[3]  
Ahmad N, 2000, CLIN CANCER RES, V6, P1524
[4]   Platinum-Induced Ototoxicity in Children: A Consensus Review on Mechanisms, Predisposition, and Protection, Including a New International Society of Pediatric Oncology Boston Ototoxicity Scale [J].
Brock, Penelope R. ;
Knight, Kristin R. ;
Freyer, David R. ;
Campbell, Kathleen C. M. ;
Steyger, Peter S. ;
Blakley, Brian W. ;
Rassekh, Shahrad R. ;
Chang, Kay W. ;
Fligor, Brian J. ;
Rajput, Kaukab ;
Sullivan, Michael ;
Neuwelt, Edward A. .
JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (19) :2408-2417
[5]   Promoting Effects of Sanguinarine on Apoptotic Gene Expression in Human Neuroblastoma Cells [J].
Cecen, Emre ;
Altun, Zekiye ;
Ercetin, Pinar ;
Aktas, Safiye ;
Olgun, Nur .
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (21) :9445-9451
[6]   Sanguinarine-induced apoptosis is associated with an early and severe cellular glutathione depletion [J].
Debiton, E ;
Madelmont, JC ;
Legault, J ;
Barthomeuf, C .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2003, 51 (06) :474-482
[7]   The alkaloid sanguinarine is effective against multidrug resistance in human cervical cells via bimodal cell death [J].
Ding, ZH ;
Tang, SC ;
Weerasinghe, P ;
Yang, XL ;
Pater, A ;
Liepins, A .
BIOCHEMICAL PHARMACOLOGY, 2002, 63 (08) :1415-1421
[8]   The protective role of tiopronin in cisplatin ototoxicity in Wistar rats [J].
Fetoni, AR ;
Quaranta, N ;
Marchese, R ;
Cadoni, G ;
Paludetti, G ;
Sergi, B .
INTERNATIONAL JOURNAL OF AUDIOLOGY, 2004, 43 (08) :465-470
[9]   Sanguinarine-induced apoptosis in human leukemia U937 cells via Bcl-2 downregulation and caspase-3 activation [J].
Han, Min Ho ;
Yoo, Young Hyun ;
Choi, Yung Hyun .
CHEMOTHERAPY, 2008, 54 (03) :157-165
[10]   Platinum-based anticancer agents: Innovative design strategies and biological perspectives [J].
Ho, YP ;
Au-Yeung, SCF ;
To, KKW .
MEDICINAL RESEARCH REVIEWS, 2003, 23 (05) :633-655